✓After hours - Last update: Oct 12, 2026, 4:44 PM ET
🛡Material / Earnings✓High confidence
Source: daily_prices:fmp_change_percent
Changes History →Market closed · After hours · 5:53 PM ET
Last update: Oct 12, 2026, 5:18 PM ETMarket closed·62 changes confirmed today
Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s
Investment research built around change detection.
Showing:
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
✓After hours - Last update: Oct 12, 2026, 4:38 PM ET
🛡Material / Earnings✓High confidence
What changed: Viavi Solutions Inc. (VIAV) moved -6.58% from $44.69 to $41.75 on 2026-10-12. The decline was driven by profit-taking after a 150% year-to-date rally, valuation concerns flagged by market commentators relative to near-term earnings, and insider selling activity totaling roughly $8 million in the prior quarter. The pullback followed a multi-week surge fueled by excitement over AI data center testing demand and the launch of the CyberFlood CF50 platform.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Viavi Solutions earnings announcement on 2026-10-28; consensus EPS estimate is $0.41.
✓After hours - Last update: Oct 12, 2026, 4:38 PM ET
⚡Material / Earnings✓High confidence
What changed: Fair Isaac Corporation (FICO) moved +9.79% on October 12, 2026, driven by short-covering after a steep multi-week decline and positive market reception to management's cost-cutting measures. The company announced a 15% workforce reduction paired with deeper AI integration to streamline operations and accelerate product development.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
FICO earnings scheduled for November 4, 2026, with consensus EPS estimate of $10.91; guidance on how workforce reduction and AI integration will offset FHFA competitive pressures will be critical.
✓After hours - Last update: Oct 12, 2026, 4:38 PM ET
🛡Material / Earnings✓High confidence
What changed: Ubiquiti Inc. (UI) moved -5.12% from $653.01 to $619.56 on 2026-10-12. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The decline appears driven by profit-taking following a period of elevated valuation multiples (P/E near 39x–44x), amplified by concentrated insider ownership that limits public float and can magnify daily swings.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
UI earnings report expected early November 2026 (consensus EPS $4.25).
✓After hours - Last update: Oct 12, 2026, 9:32 AM ET
🛡Valuation✓High confidence
Intraday updates3 updates
3:50 PM ETLATESTValuation✓ High confidence
Cerebras stock fell 10.36% to $147.17, driven by OpenAI partnership concerns and share lockup pressures. According to Barron's, industry reports (SemiAnalysis) suggest OpenAI's GPT-6.1 Sol is using Nvidia GPUs rather than Cerebras hardware, undermining confidence in the key commercial relationship despite reassurances from CEO Sam Altman. Volume surged to 10.4M shares—2.96x the historical average at this point in the session—as approaching lockup expirations flood the market with newly eligible supply.
12:20 PM ETValuation✓ High confidence
Cerebras stock fell 5.74% to $154.74, extending a multi-week pullback driven by persistent investor concerns over OpenAI workload shifts to Nvidia GPUs and margin pressure. Although OpenAI CEO Sam Altman publicly called Cerebras a "close partner" (per Benzinga), the market remains anxious about potential customer concentration risk. Recent earnings also showed gross margins slipping to ~40.6% and slowed revenue growth guidance, adding pressure on a stock trading at a steep valuation relative to traditional chipmakers.
9:40 AM ETRisk✓ High confidence
Cerebras Systems fell 2.39% to $160.24 following reports that OpenAI has shifted key high-speed workloads toward Nvidia GPUs rather than relying exclusively on Cerebras hardware, despite CEO Sam Altman's prior reassurances about the partnership (CNBC, Yahoo Finance, Benzinga). The decline reflects broader investor concern over Nvidia's competitive dominance and Cerebras' unprofitable growth profile, compounded by ongoing post-IPO lock-up expirations and insider selling that have pushed the stock well below its May 2026 IPO price of $185.
What's next
What to watch
CBRS earnings on 2026-11-12 (consensus EPS estimate −$0.15); confirmation of OpenAI hardware deployment and any guidance on lockup-related dilution.
✓After hours - Last update: Oct 12, 2026, 10:17 AM ET
📊Valuation✓High confidence
What changed: Semtech Corporation fell 7.05% to $174.09 on intraday trading, though no immediate catalyst event or news announcement is evident in available sources as of 45 minutes into the session. The decline occurs ahead of an upcoming Data Center Analyst Day scheduled for October 15, 2026, and Q3 earnings due November 23, 2026.
Detected Oct 12, 3:50 PM ET
Changes History →What's next
What to watch
Semtech Data Center Analyst Day on October 15, 2026, and earnings announcement on November 23, 2026 (consensus EPS $1.06).
✓After hours - Last update: Oct 12, 2026, 10:12 AM ET
🛡Valuation✓High confidence
Intraday updates2 updates
3:50 PM ETLATESTValuation✓ High confidence
Ciena fell 10.60% to $402.09 amid a sector-wide pullback in AI infrastructure and optical networking stocks, per Investing.com. The decline reflects profit-taking after a strong multi-week rally and high valuation multiples relative to historical and peer averages, compounded by weakness across peers like Lumentum and Coherent around industry events such as the OCP Global Summit. Volume remained normal at 1.01x expected for this time of session.
2:30 PM ETRisk✓ High confidence
Ciena fell 6.48% to $420.61 on intraday trading, though no market-moving catalyst was identified in real-time news or announcements. The company reported record Q3 results on 2026-10-12 reflecting strong AI and data center demand with rising margins (per Zacks), and announced a Chief People Officer appointment the same day (Business Wire). The magnitude of today's decline suggests either a delayed negative reaction to guidance, a sector-wide pullback, or a technical unwind — volume data remains unreliable at 40 minutes into the session.
What's next
What to watch
Ciena earnings scheduled for 2026-12-10; consensus EPS estimate is $2.05. Monitor peers' guidance and sector commentary on AI optical demand to assess whether the pullback is tactical or signals broader infrastructure spending concerns.
✓After hours - Last update: Oct 12, 2026, 3:51 PM ET
📊Valuation✓High confidence
What changed: Oklo fell 6.77% to $32.35 as nuclear energy and small modular reactor (SMR) stocks retreated broadly, with peer NuScale Power sliding similarly (247wallst.com, zacks.com). The sector-wide pullback reflects investor caution on pre-revenue nuclear developers facing extended timelines before commercial deployments and rising cash burn projections of $120–$150 million for 2026 (web_catalyst). Volume of 7.76M shares traded at 0.75x historical average, suggesting below-average participation at this session stage.
Detected Oct 12, 3:50 PM ET
Changes History →What's next
What to watch
Oklo earnings (scheduled 2026-11-10, consensus EPS −$0.29); updated 2026 cash burn and deployment timeline guidance for its Aurora plant.
✓After hours - Last update: Oct 12, 2026, 2:21 PM ET
📊Valuation✓High confidence
What changed: Planet Labs stock fell 6.02% to $16.14 amid macroeconomic headwinds, elevated Treasury yields (10-year near 5.3%), and investor concerns over valuation and dilution from its $1.5 billion at-the-market equity offering, per Benzinga and Yahoo Finance. Volume remains below average at 0.60x the typical pace 290 minutes into the session.
Detected Oct 12, 3:50 PM ET
Changes History →What's next
What to watch
Planet Labs earnings scheduled for December 9, 2026 (consensus EPS: −$0.02); monitor Treasury yields and sector rotation flows in satellite/space stocks.
✓After hours - Last update: Oct 12, 2026, 1:51 PM ET
📊Valuation✓High confidence
What changed: Carvana (CVNA) fell 5.41% to $60.28 as investors adopt a cautious stance ahead of the company's Q3 earnings report (scheduled Oct. 28, 2026) amid broader market pullbacks and sector-wide concerns about agentic AI's potential impact on online auto retail. Volume remained below average at 0.70x expected for this point in the session, per FMP data, suggesting measured selling rather than panic liquidation.
Detected Oct 12, 3:50 PM ET
Source: ca.finance.yahoo.com ↗
Changes History →What's next
What to watch
Carvana Q3 2026 earnings report on October 28, 2026 (consensus EPS estimate: $0.44); monitor per-vehicle margin trends and guidance commentary on consumer credit and used-auto demand.
✓After hours - Last update: Oct 12, 2026, 12:42 PM ET
🛡Valuation✓High confidence
Intraday updates2 updates
3:40 PM ETLATESTValuation✓ High confidence
Compass, Inc. (COMP) fell 5.43% to $8.88 amid a confluence of legal and regulatory pressures: fresh antitrust and MLS scrutiny in Texas alongside ongoing listing-data disputes with Zillow, per the web catalyst. Simultaneously, multiple securities class-action lawsuits were announced via PR Newswire (DJS Law Group, Robbins LLP), citing alleged securities law violations. Trading volume stood at 5.18M shares (0.59x expected for this time of day), below average.
12:40 PM ETRisk✓ High confidence
Compass, Inc. (COMP) fell 5.43% to $8.88 as multiple securities class action lawsuits against the company were announced via PR Newswire, with law firms Robbins LLP and DJS Law Group each filing or promoting investor participation in claims alleging securities law violations. The decline occurred on below-average volume (0.54x expected for 190 minutes into session), suggesting limited institutional participation in the selloff.
What's next
What to watch
Earnings scheduled for November 3, 2026 (consensus $0.05 EPS); monitor for any updates on the Texas antitrust matter, MLS settlement discussions, or Zillow data-sharing negotiations.
✓After hours - Last update: Oct 12, 2026, 11:51 AM ET
📊Valuation✓High confidence
What changed: Legence (LGN) fell 3.20% to $49.88 on analyst downside pressure: Stifel Nicolaus (analyst Brian Brophy) lowered its price target to $82.00 on October 8, 2026, maintaining a Buy rating but signaling reduced near-term upside. The decline also reflects lingering headwinds from Q2 earnings that included $41.08 million in asset impairments and ongoing private equity stake reductions by Blackstone. Volume sits at 0.56x expected for this stage of the session, indicating below-average engagement.
Detected Oct 12, 3:50 PM ET
Changes History →What's next
What to watch
Legence Q3 2026 earnings report on November 13, 2026 (consensus EPS estimate $0.57); monitor whether management addresses the asset impairments and private equity position changes.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.
Stock AnalysisOctober 12, 2026 · 10 min read
IonQ (IONQ) Falls ~9% on a $1.3B All-Stock Cybersecurity Acquisition
IonQ fell about 9% to roughly $36 on October 12 on a day it announced a definitive agreement to acquire Elisity, a zero-trust cybersecurity company, in an all-stock deal worth up to $1.3 billion. The counterintuitive part is the point: a stock dropping on its own acquisition. The all-stock structure is why — IonQ's share count is already up about 50% over the past year as it funds an acquisition-and-fundraising spree largely with stock, and Elisity is its third billion-dollar-scale deal in roughly 16 months, after the mostly-stock Oxford Ionics purchase and the cash-and-stock SkyWater acquisition. The strategic logic is forward-looking (pairing post-quantum cryptography with Elisity's zero-trust platform to sell 'quantum-era' security), but the market read the news as more dilution and more strategic sprawl from a pre-profit company valued near $14 billion on just $246 million of revenue — about 58 times sales, with an operating margin near negative 380%. A sign of company-specific pressure: IonQ fell about 9% while quantum peers Rigetti and D-Wave fell closer to 5.5% and the Nasdaq-100 slipped under 1% — more than the sector alone would explain. Wall Street stays overwhelmingly bullish on the long-term quantum roadmap — a Strong Buy consensus with an average target far above the price — which is exactly why a story stock like this swings so violently on news.
IONQRead →
Stock AnalysisOctober 12, 2026 · 10 min read
Manhattan Associates (MANH) Jumps ~6% on a Morgan Stanley Upgrade to Overweight
Manhattan Associates jumped about 5.5% to roughly $216 on October 12 — after running as high as about $221 — on a Morgan Stanley upgrade to Overweight from Equalweight and a price-target raise to $250 from $180. The move bucked a down software tape: supply-chain peers were flat and the software sector fell, marking this as an idiosyncratic, catalyst-driven move. Analyst Chris Quintero leaned on three points — accelerating cloud subscription bookings under CEO Eric Clark, a narrative shift from Manhattan being seen as AI-vulnerable to an AI beneficiary via its agentic-AI suite, and a more attractive valuation — while citing only about 1–2% upside to consensus revenue, a tell that this is a re-rating of sentiment as much as of the numbers. The business is a genuinely profitable, cash-generative franchise (56% gross margins, ~25% operating margins, a net-cash balance sheet, ~$400M of free cash flow, cloud revenue up in the mid-20s percent), but it is not cheap: near a 52-week high at ~62x trailing and ~37x forward earnings after a ~70% six-month run, the upgrade pushed it to within a few percent of the ~$228 average analyst target. The next hard test is third-quarter earnings on October 27.
MANHRead →
Stock AnalysisOctober 8, 2026 · 9 min read
Chipotle (CMG) Surges ~6% on a Report Starbucks Explored a Takeover
Chipotle jumped about 6% to roughly $32.54 on October 8 — after running as high as about $33.40 — on a Financial Times report that Starbucks has explored a potential takeover of the burrito chain. The key word is explored: the report describes preliminary, exploratory interest, not a formal offer, and neither company confirmed a deal, so this is a stock moving on takeover speculation that could reverse if the idea goes no further. The speculation still landed hard — volume ran about three times normal — because a Starbucks–Chipotle combination would be enormous (nearly $50 billion in combined sales, potentially the largest restaurant deal ever if completed) and would reunite Starbucks CEO Brian Niccol with the chain he ran from 2018 to 2024. It resonated partly because Chipotle had become cheap for Chipotle: down about 19% over the past year and trading below the ~$44 average analyst target even after the pop, a high-quality, cash-generative brand at a discount is exactly the profile that draws suitors. But skepticism is warranted: Starbucks fell about 3% on the prospect of a $45-billion-plus deal that would strain its balance sheet mid-turnaround, the strategic fit between coffee and fast-casual Mexican is debatable, and exploratory interest frequently never becomes an offer. The classic M&A-speculation cross-section — target up, acquirer down, McDonald's higher — tells the story; the next hard data is Chipotle's October 28 earnings.
CMGRead →
Stock AnalysisOctober 7, 2026 · 10 min read
NetApp (NTAP) Rises ~3.5% as Evercore Upgrades to a Street-High $300 on AI Storage
NetApp outperformed a weaker broader market on October 7, rising about 3.5% to roughly $236.50 after Evercore ISI's Amit Daryanani upgraded the stock from In Line to Outperform and set a Street-high $300 price target, up from $210. The move was less about one call than the cluster behind it: over roughly a week, Loop Capital went to $260, TD Cowen to $250, and Goldman to $240, and Evercore has now leapfrogged them all with a rating upgrade — a sell-side re-rating of NetApp as an AI-storage beneficiary, its all-flash arrays and ONTAP software positioned for the data pipelines that feed GPU clusters (a story reinforced by its late-September deal to buy PEAK:AIO and its Novus launch, both earlier developments rather than a fresh catalyst). NetApp rose even as long-dated Treasury yields hit their highest since 2002 in a rates- and oil-driven risk-off that pressured high-multiple shares. But the stock is not cheap: up roughly 96% over the past year, it trades near 23 times forward earnings and 6 times sales for a business growing revenue in the low-double-digits, so the upgrades are betting AI lifts both growth and the multiple. And the Street is genuinely split — the published average target near $206 sits below the price, reflecting both the lag before the newest hikes propagate and real disagreement: a camp of fresh below-price targets (Wedbush's Hold at $170, plus Citi, Barclays and Bank of America in the $190–$220 range) against the bulls at $240–$300. Without an unusually heavy-volume surge, this is a sell-side re-rating; the fundamentals arrive with December 1 earnings.
NTAPRead →
Stock AnalysisOctober 5, 2026 · 9 min read
Vaxcyte (PCVX) Surges ~35% as VAX-31 Meets All Primary Endpoints in Pivotal Phase 3 Trial
Vaxcyte surged to roughly $76 on October 5 — up about 35% after opening near $87 (about +54%) — when it reported positive topline data from OPUS-1, the pivotal adult Phase 3 trial of VAX-31, its 31-valent pneumococcal conjugate vaccine. The trial met all of its prespecified primary endpoints on immune-response and safety measures: in adults 50 and older, VAX-31 met non-inferiority on all 20 serotypes it shares with Pfizer's Prevnar 20 and 17 of the 19 it shares with Merck's Capvaxive (the two exceptions cleared only a less-stringent historical bar), and superiority on the three serotypes unique to VAX-31, with safety similar to the incumbents. It is the profile a broader, 31-valent shot needs to take share in a multi-billion-dollar adult pneumococcal market — and the market priced it as a transfer of value, with Pfizer down about 1.6% and Merck about 3.4% while the biotech index was flat. Vaxcyte is still a clinical-stage, pre-revenue company — a roughly $1 billion annual loss, no P/E, and years from revenue, with two more Phase 3 trials due in 2027 and a planned filing in 2028 — but about $2.5 billion of cash and investments gives it runway, and sell-side targets sit well above the current price (Guggenheim raised its target to $125 the same day; Mizuho and Jefferies reiterated standing Buys at $163 and $146). The stock's gap-up-then-fade captures the tension between clearly good data and the execution still ahead.
PCVXRead →
Stock AnalysisOctober 5, 2026 · 10 min read
PTC Inc. (PTC) Jumps ~35% as Schneider Electric Agrees to a $22.6 Billion Cash Takeover
PTC Inc. jumped about 35% to roughly $194.49 on October 5 after Schneider Electric agreed to acquire the industrial-software maker in an all-cash deal at $205 a share — valuing PTC's equity near $22.6 billion, a 42.3% premium to Friday's close, in what would be Schneider's largest acquisition ever. With a firm cash bid in hand, the stock stopped trading on fundamentals and started trading on deal arithmetic: it gapped toward the offer but settled about 5% below it, a merger spread that prices the time and risk to a close expected by the third quarter of 2027, subject to a PTC shareholder vote and antitrust and CFIUS clearances. The logic is industrial software and AI — PTC's design and lifecycle tools (Creo, Windchill) carry an 84% gross margin and about $935 million of free cash flow, and the company had de-rated with the software group on AI fears, which is what made it available at a price Schneider would pay a premium over. The deal is also a read-through for the sector: design-software peers like Autodesk and Dassault Systèmes rose in sympathy as the price reframed what these assets are worth, while Loop Capital, Baird and Rosenblatt all moved PTC toward Hold/Neutral at the deal price — the textbook reaction to a fixed cash bid. The investment question now is simply whether the deal closes.
PTCRead →